Friday, September 04, 2020 3:32:39 PM
Clinical Laboratory Improvement Amendments (CLIA);
Diagnostic testing helps health care providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care. The Clinical Laboratory Improvement Amendments (CLIA) regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing. Laboratories can obtain multiple types of CLIA certificates, based on the kinds of diagnostic tests they conduct.
Three federal agencies are responsible for CLIA: The Food and Drug Administration (FDA), Center for Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC). Each agency has a unique role in assuring quality laboratory testing.
FDA
Categorizes tests based on complexity
Reviews requests for Waiver by Application
Develops rules/guidance for CLIA complexity categorization
CMS
Issues laboratory certificates
Collects user fees
Conducts inspections and enforces regulatory compliance
Approves private accreditation organizations for performing
inspections, and approves state exemptions
Monitors laboratory performance on Proficiency Testing (PT)
and approves PT programs
Publishes CLIA rules and regulations
CDC
Provides analysis, research, and technical assistance
Develops technical standards and laboratory practice
guidelines, including standards and guidelines for cytology
Conducts laboratory quality improvement studies
Monitors proficiency testing practices
Develops and distributes professional information and
educational resources
Manages the Clinical Laboratory Improvement Advisory
Committee (CLIAC)
https://www.fda.gov/medical-devices/ivd-regulatory-assistance/clinical-laboratory-improvement-amendments-clia
Certificate of Registration
The Certificate of Registration is the certificate that is initially issued to a laboratory that has applied for a Certificate of Compliance or a Certificate of Accreditation. This certificate enables the laboratory to conduct moderate and/or high complexity laboratory testing until the survey is performed and the laboratory found to be in compliance with the CLIA regulations.
The Certificate of Registration includes PPM and waived testing as well as all moderate and high complexity testing.
Inspections are required for all Certificate of Registration laboratories. The inspection will be conducted between 90 days and 12 months after the effective date of the certificate in order to permit observation of actual testing during the survey.
https://ldh.la.gov/index.cfm/page/777
https://www.cdc.gov/clia/LabSearch.html
Been connecting dots,
Been saying FEMA/. gov
This is our hold up for QuikLAB testing.
TPTW is dotting "i's" & crossing "t's" on this one!!
Cheers
Recent TPTW News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 02:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:18:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 02:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/10/2024 09:24:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:06:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:43:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 01:31:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 07:44:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 05:49:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 07:18:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/05/2023 09:02:48 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM